These findings demonstrate that Apoa4 may serve as a key regulator of metabolic-immune crosstalk, maintaining metabolic and immune homeostasis during early obesity-related CKD. The gene discussed is APOA4; the disease is obesity due to melanocortin 4 receptor deficiency.